Business
JPMorgan downgrades Clorox, says rising costs will drag down earnings in the year ahead
Clorox beat estimates for its fiscal first quarter, however its outlook carries dangers, in accordance with JPMorgan.
Clorox beat estimates for its fiscal first quarter, however its outlook carries dangers, in accordance with JPMorgan.